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INTRODUCTION 
Microspheres are defined as homogenous, monolithic 
particles in the size range of about 1.0 – 1000 μm and are 
widely used as drug carriers for Sustained release. 
Administration of the drug in the form of microspheres 
usually improves the action by providing the localization 
of the active substance at the site of action and by 
sustaining the release of drugs. Glutaraldehyde was used 
as cross-linking agent to extent the release of the drug 
from the formulation. It may have more advantage to 
deliver this drug in a sustained release dosage form. The 
present study was focused on development of sustained 
release Imatinib mesylate using Chemical Cross linking 
method. Imatinib Mesylate is currently registered in adults 
for two indications: (a) monotherapy in Chronic Myeloid 
Leukemia (CML) and (b) Metastatic Gastrointestinal 
Stromal Tumors (GISTs). 
EXPERIMENTAL  
Materials 
Imatinib Mesylate1,2 was procured as a gift sample from 
Natco Pharma Limited, Mumbai (India). Sodium 
Alginate3-6 was obtained from Safe Pharma, Narasaraopet 
as gift sample. All chemicals were of analytical grade and 
were used without further purification. 
Method of preparation
7-9
 
A 4.0% (w/v) Polymer solution in aqueous acetic acid 
(5.0%) was prepared. This dispersed phase was added to 
continuous phase (100 mL) consisting of light liquid 
paraffin and 25ml of Petroleum ether containing 2.0ml of 
Span 80 in a beaker at room temperature. Stirring was 
continued at 2000 rpm using a 3 - blade half moon paddle 
for 5 minutes. A drop-by-drop solution of a measured 
quantity (2.5 mL each) of aqueous glutaraldehyde (25% 
v/v) saturated with toluene was added at 15, 30, 45, and 
60 minutes. Stirring was continued for 2.0 hours and 
separated by centrifugation and washed, first with 
petroleum ether (60°C - 80°C) four times, once with 
acetone and then thrice with distilled water to remove the 
adhered liquid paraffin and glutaraldehyde, respectively. 
The microspheres were then finally dried at room 
temperature and stored in vacuum desiccators. 
Compatibility studies
10,11
 
One of the requirements for the selection of suitable 
carrier for pharmaceutical formulation was compatibility. 
Therefore in the present work a study was carried out by 
using FTIR spectrophotometer to find out if there are any 
possible chemical interactions between Imatinib mesylate, 
sodium Alginate. 
           
Figure 1: FCC3 Optimised formulation     
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Figure 2: FCC3 Optical microscopic photo 
Particle size analysis
12-14
 
The microsphere size distribution was determined by the 
optical microscopy method using a calibrated stage 
micrometer (μm). 
Angle of repose  
The fractional force in the loose powder can be measured 
by the angle of repose. Angle of repose was calculated by 
static method using fixed funnel method. This was the 
maximum angle possible between the surfaces of the site 
of the powder to the horizontal plane. 
Determination of bulk density  
The bulk density was determined by 3-tap method. Bulk 
density is defined as, “the mass of powder divided by the 
bulk volume”. The packing characteristics of the powder 
play an important role in determining physical properties 
of product. 
Table 1: Micromeritic Evaluation of Microspheres 
Formulation 
Code 
Particle size 
 
Angle of Repose Bulk Density Tapped Density Carr‟s Index Hausner‟s 
Ratio 
FCC1 100.45±1.906 21.59±1.073 0.845±0.010 0.965±0.012 12.40±0.928 1.27±0.240 
FCC2 102.88±3.042 21.59±1.532 0.850±0.002 0.970±0.021 12.34±2.068 1.14±0.027 
FCC3 105.08±1.981 23.11±0.587 0.846±0.016 0.970±0.028 12.64±4.117 1.15±0.052 
FCC4 104.28±1.825 23.01±0.907 0.853±0.008 0.969±0.023 9.82±1.376 1.11±0.016 
FCC5 107.62±2.385 23.15±0.530 0.831±0.020 0.955±0.014 12.91±3.443 1.14±0.044 
 
Determination of drug content  
Accurately weighed microspheres equivalent to 25mg of 
Imatinib mesylate, crushed in glass mortar and pestle and 
the powdered microspheres were suspended in 100 mL of 
0.1N HCl. After 24 hours, the solution was filtered and the 
filtrate was analyzed for the drug content. 
Encapsulation efficiency
15
  
Encapsulation efficiency was calculated using the 
following formula; 
100
%
%

ContentDruglTheoretica
ContentDrugEstimated
EfficiencyionEncapsulat  
In- vitro dissolution studies
16,
  
The drug release study was performed using USP XXIII 
dissolution test apparatus, the capsules filled with 
equivalent amount of Imatinib Meyslate 100 mg was 
placed in a basket. The instrument was set at 100 - rpm 
rotation and at 32⁰C, 900 mL of 0.1N HCl was filled as 
dissolution medium for first 2 hours and phosphate buffer 
pH 7.4 for remaining period. Samples were withdrawn at 
predetermined intervals, from 0.5 – 24 hours filtered and 
analyzed spectrophotometrically at 230 nm using 
corresponding medium as blank. After each withdrawal, 
the same quantity of fresh medium was replaced 
immediately. 
Kinetic characteristics of the drug release
17-19
 
To know the mechanism of the drug release from the 
microspheres, the results obtained from the In-vitro 
dissolution process were fitted into different kinetic 
equations as follows: 
1. Zero - order drug release: Cumulative % drug release 
Vs Time. 
2. First order drug release: Log cumulative % drug 
retained Vs Time. 
3. Higuchi‟s classical diffusion equation: Cumulative % 
drug release Vs Square root of time. 
4. Peppa‟s Korsemeyer Exponential equation: Cumulative 
% drug release Vs Log time. 
„n‟ values can be used to characterize diffusion release 
mechanism. 
Stability studies
20
 
The Optimised preparation was divided into 3 sets and 
was stored at 4°C (refrigerator), room temperature and 
40°C (thermostatic oven). After 15, 30, 60, 90 drug 
content and SEM of the formulation was determined. 
RESULTS AND DISCUSSION 
We formulated 5 formulations using sodium alginate with 
different ratios. The characterisation of formulations were 
studied in particle size, angle of repose, bulk density, 
tapped density, percentage yield, drug content, Hausner‟s 
ratio, carr‟s index and cumulative percentage of drug 
release. The sustained release microspheres of all batches 
were found to be spherical and free flowing nature based 
on the SEM analysis. FTIR studies said that there were no 
incompatability between drug and polymer. Formulated 
microsphere particle size showed the range from 107.62 
(FCC5) - 100.45 (FCC1). The angle of repose for the 
formulated microspheres found to be within the range 
23.15-21.59 and showed moderate to good flow in nature. 
The formulation shows the bulk density values are from 
0.970-0.955 indicating moderate flow characterstics of 
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microspheres. The percentage yield of the formulations 
were 81.35 (FCC1) - 86.42 (FCC3). The drug content was 
started from 22.18 (FCC3) to 19.61 (FCC1). The drug 
encapsulation efficiency was found to be 789.05 - 87.12 
and said that drug polymer blend was good to made 
microspheres. Stability studies stated that ther was not 
much difference in the drug content and slight difference 
in the SEM analysis. The In-vitro drug release for all 
formulation was found to follw Non- Fickian diffusion 
release kinetics. 
Table 2: Evaluation of Microspheres 
Formulation 
Code 
% yield 
 
Encapsulation 
Efficiency 
Drug Content 
 
In-vitro Release 
 
„n‟ Value R2 Value 
 
FCC1 81.35±0.579 79.05±0.540 19.61±0.374 99.01±0.273 0.637 0.993 
FCC2 84.05±0.912 83.71±0.665 20.85±0.692 99.38±0.209 0.615 0.996 
FCC3 86.42±0.290 87.12±1.378 22.18±0.470 99.60±0.238 0.615 0.992 
FCC4 83.70±0.461 79.47±0.506 21.73±1.070 97.64±0.422 0.540 0.944 
FCC5 84.33±0.494 81.37±0.865 20.21±0.420 98.65±0.349 0.630 0.995 
 
 
Figure 1: Cumulative % release of Microspheres 
CONCLUSION 
From our study, it was concluded that the Imatinib 
Mesylate (α-form) loaded microspheres prepared by cross-
linking agent Glutaraldehyde with Sodium Alginate with 
different ratios showed decreased in the release rate of 
drug from the formulation depending on the concentration 
of the polymers. The concentration of the polymers 
influenced the drug release pattern and polymer 
impregmentation depending upon cross-linking agent. The 
formulation with drug and polymers in 1:3 ratio (FCC3) 
with cross linking agent maximum concentration was 
considered best because, it showed retard drug release in 
pH 7.4 buffer was found to be 99.60% almost complete 
and uniform after the 24hour release study. Drug 
encapsulation efficiency for formulation (FCC3) was 
87.12% w/w and all the remaining parameters were within 
the prescribed limit. Stability studies showed that the 
optimised formulation not much altered the drug content 
and SEM report. Optimised formulations toxicological 
study was done and observed data were showed that no 
significance of toxicological difference. As per the results 
concluded hte formulation FCC3 fully satisfy in all 
expectation.  
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